EP2511283A4 - N6-substituierte adenosinderivate, n6-substituierte adeninderivate und ihre verwendung - Google Patents
N6-substituierte adenosinderivate, n6-substituierte adeninderivate und ihre verwendungInfo
- Publication number
- EP2511283A4 EP2511283A4 EP09851974.7A EP09851974A EP2511283A4 EP 2511283 A4 EP2511283 A4 EP 2511283A4 EP 09851974 A EP09851974 A EP 09851974A EP 2511283 A4 EP2511283 A4 EP 2511283A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- substituted
- derivatives
- adenosine
- adenine
- adenosine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2009/075478 WO2011069294A1 (zh) | 2009-12-10 | 2009-12-10 | N6-取代腺苷衍生物和n6-取代腺嘌呤衍生物及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2511283A1 EP2511283A1 (de) | 2012-10-17 |
EP2511283A4 true EP2511283A4 (de) | 2013-07-03 |
Family
ID=44145091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09851974.7A Withdrawn EP2511283A4 (de) | 2009-12-10 | 2009-12-10 | N6-substituierte adenosinderivate, n6-substituierte adeninderivate und ihre verwendung |
Country Status (6)
Country | Link |
---|---|
US (1) | US10174033B2 (de) |
EP (1) | EP2511283A4 (de) |
JP (1) | JP2013513551A (de) |
CN (1) | CN102812033B (de) |
CA (1) | CA2783859A1 (de) |
WO (1) | WO2011069294A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ597050A (en) | 2009-06-29 | 2014-02-28 | Incyte Corp | Pyrimidinones as pi3k inhibitors |
US8759359B2 (en) | 2009-12-18 | 2014-06-24 | Incyte Corporation | Substituted heteroaryl fused derivatives as PI3K inhibitors |
EP2558463A1 (de) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Kondensierte derivate als i3-hemmer |
WO2011163195A1 (en) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
AR084366A1 (es) | 2010-12-20 | 2013-05-08 | Incyte Corp | N-(1-(fenil sustituido)etil)-9h-purin-6-aminas como inhibidores de pi3k |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
WO2012135009A1 (en) | 2011-03-25 | 2012-10-04 | Incyte Corporation | Pyrimidine-4,6-diamine derivatives as pi3k inhibitors |
BR122019020716B1 (pt) | 2011-09-02 | 2021-02-17 | Incyte Holdings Corporation | heterociclilaminas como inibidores de pi3k e composição farmacêutica que as compreende |
US20150038445A1 (en) * | 2012-02-11 | 2015-02-05 | Academia Sinica | Methods and compositions for treating pain |
AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
NZ710444A (en) * | 2013-02-11 | 2020-08-28 | Univ California | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy |
CN104173363B (zh) * | 2013-05-28 | 2019-12-13 | 中国医学科学院药物研究所 | 一种腺苷化合物在制备防治应激障碍药物中的用途 |
SG11201603063WA (en) | 2013-10-23 | 2016-05-30 | Academia Sinica | Compounds for use in prevention and treatment of neurodegenerative diseases and pain |
WO2015123365A1 (en) | 2014-02-11 | 2015-08-20 | Mitokinin Llc | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
US10077277B2 (en) | 2014-06-11 | 2018-09-18 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors |
US20160024135A1 (en) * | 2014-07-27 | 2016-01-28 | Zhejiang Subtropical Crops Research Institute | Adenosine receptor activation reagent and the uses of thereof |
TWI668007B (zh) * | 2014-11-11 | 2019-08-11 | 中央研究院 | 用於預防及治療神經退化疾病及疼痛之化合物 |
TWI650328B (zh) * | 2014-11-11 | 2019-02-11 | 中央研究院 | 用於預防及治療神經退化疾病及疼痛之化合物 |
CZ308881B6 (cs) * | 2014-12-09 | 2021-08-04 | Univerzita Palackého v Olomouci | 6-aryl-9-glykosylpuriny a jejich použití |
MD3262046T2 (ro) | 2015-02-27 | 2021-03-31 | Incyte Corp | Săruri de inhibitori ai PI3K și procedee pentru prepararea lor |
US9732097B2 (en) | 2015-05-11 | 2017-08-15 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
WO2016183063A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Crystalline forms of a pi3k inhibitor |
WO2018140734A1 (en) | 2017-01-27 | 2018-08-02 | Academia Sinica | Compound with analgesic effect for use in prevention and treatment of pain |
WO2018237145A1 (en) | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | COMPOSITIONS AND METHODS USING THEM FOR THE TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE |
CN117338801A (zh) * | 2023-11-13 | 2024-01-05 | 河北医科大学 | N6-取代腺苷衍生物或n6-取代嘌呤衍生物在制备减轻围术期神经炎症药品中的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004058791A2 (en) * | 2002-12-30 | 2004-07-15 | Ustav Experimentalni Botaniky Akademie Ved Ceske Republiky | Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
WO2005084653A2 (en) * | 2004-03-05 | 2005-09-15 | Cambridge Biotechnology Limited | Adenosine receptor agonists |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL128629C (de) * | 1966-05-07 | |||
NL130136C (de) * | 1966-10-20 | |||
DE1962387C2 (de) * | 1969-12-12 | 1983-08-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | N↑6↑-(3-Chlorbuten(2)-yl)-adenosin |
US4593019A (en) * | 1984-10-26 | 1986-06-03 | Warner-Lambert Company | N6 -tricyclic adenosines |
GB9723590D0 (en) * | 1997-11-08 | 1998-01-07 | Glaxo Group Ltd | Chemical compounds |
US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
US20050187389A1 (en) * | 2004-01-13 | 2005-08-25 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
HUE035188T2 (en) | 2009-11-13 | 2018-05-02 | Academia Sinica | Adenosine A2A receptor and adenzoin transporter double acting compounds for the prevention and treatment of neurodegenerative diseases |
-
2009
- 2009-12-10 US US13/515,152 patent/US10174033B2/en not_active Expired - Fee Related
- 2009-12-10 CN CN200980162826.5A patent/CN102812033B/zh active Active
- 2009-12-10 WO PCT/CN2009/075478 patent/WO2011069294A1/zh active Application Filing
- 2009-12-10 EP EP09851974.7A patent/EP2511283A4/de not_active Withdrawn
- 2009-12-10 JP JP2012542331A patent/JP2013513551A/ja active Pending
- 2009-12-10 CA CA2783859A patent/CA2783859A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004058791A2 (en) * | 2002-12-30 | 2004-07-15 | Ustav Experimentalni Botaniky Akademie Ved Ceske Republiky | Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds |
WO2005084653A2 (en) * | 2004-03-05 | 2005-09-15 | Cambridge Biotechnology Limited | Adenosine receptor agonists |
Non-Patent Citations (11)
Title |
---|
AFIFY H M N M ET AL: "A NOVEL AND FACILE REACTION TO N6-ALKYLATED ADENOSINE VIA BENZOTRIAZOLE AS A SYNTHETIC AUXILIARY", JOURNAL OF HETEROCYCLIC CHEMISTRY, WILEY-BLACKWELL PUBLISHING, INC, US, vol. 37, no. 2, 1 March 2000 (2000-03-01), pages 339 - 341, XP001147847, ISSN: 0022-152X, DOI: 10.1002/JHET.5570370218 * |
BRESSI JC ET AL: "Adenosine analgoues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N6-subsituted adenosine", JOURNAL OF MEDICINAL CHEMISTRY, vol. 43, 12 October 2000 (2000-10-12), pages 4135 - 4150, XP002695882 * |
CAPPELACCI L ET AL: "RIBOSE-MODIFIED PURINE NUCLEOSIDES AS RIBONUCLEOTIDE REDUCTASE INHIBITORS. SYNTHESIS, ANTITUMOR ACTIVITY, AND MOLECULAR MODELING OF N6-SUBSTITUTED 3'-C-METHYLADENOSINE", JOURNAL OF MEDICINAL CHEMISTRY, vol. 51, 28 June 2008 (2008-06-28), pages 4260 - 4269, XP002695883 * |
DE ZWART M ET AL: "A FUNCTIONAL SCREENING OF ADENOSINE ANALOGUES AT THE ADENOSINE A2B RECEPTOR: A SEARCH FOR POTENT AGONISTS", NUCLEOSIDES & NUCLEOTIDES, MARCEL DEKKER INC, vol. 17, no. 6, 1 January 1998 (1998-01-01), pages 969 - 985, XP002108781, ISSN: 0732-8311 * |
HA ET AL: "new base-altered adenosine analogues: synthesis and affinity at adenosine A1 and A2 receptors", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 7, no. 24, 1 November 1997 (1997-11-01), pages 3085 - 3090 * |
KAREL DOLEZAL ET AL: "Preparation, biological activity and endogenous occurrence of N6-benzyladenosines", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, no. 11, 1 June 2007 (2007-06-01), pages 3737 - 3747, XP055103745, ISSN: 0968-0896, DOI: 10.1016/j.bmc.2007.03.038 * |
LETHAM ET AL: "Cytokinins from Zea Mays", PHYTOCHEMISTRY, vol. 12, 1 January 1973 (1973-01-01), pages 2445 - 2455 * |
ROIVAINEN J ET AL: "An enzymatic transglycosylation of purine bases", NUCLEOSIDES, NUCLEOTIDES AND NUCLEIC ACIDS, vol. 26, 1 January 2007 (2007-01-01), pages 905 - 909, XP002695884 * |
See also references of WO2011069294A1 * |
WALSH: "Kinetics of nucleophilic substitution on 6-chloropurine ribonucleoside in aqueous solution", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 89, no. 24, 22 November 1967 (1967-11-22), pages 6221 - 6225 * |
Z-G GAO ET AL: "N6-Substituted adenosine derivatives: selectivity, efficacy, and species differences at A3 adenosine receptors", 20030101; 20030000, vol. 65, 1 January 2003 (2003-01-01), pages 1675 - 1684, XP002309313 * |
Also Published As
Publication number | Publication date |
---|---|
US20130045942A1 (en) | 2013-02-21 |
CN102812033B (zh) | 2015-11-25 |
JP2013513551A (ja) | 2013-04-22 |
CA2783859A1 (en) | 2011-06-16 |
US10174033B2 (en) | 2019-01-08 |
EP2511283A1 (de) | 2012-10-17 |
WO2011069294A1 (zh) | 2011-06-16 |
CN102812033A (zh) | 2012-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2511283A4 (de) | N6-substituierte adenosinderivate, n6-substituierte adeninderivate und ihre verwendung | |
HRP20171398T1 (hr) | Novi derivati adenina | |
HRP20181774T1 (hr) | Novi citostatski 7-deazapurinski nukleosidi | |
HK1203488A1 (en) | Pyrimidine substituted purine derivatives | |
ZA201008829B (en) | Nucleoside cyclicphosphates | |
AP2011005929A0 (en) | Substituted nucleoside and nucleotide analogs. | |
ME02100B (me) | Derivati 4-aminopirimidina i njihova primena kao antagonista adenozinskog a2a receptora | |
HK1167392A1 (en) | Adenosine receptor ligands and uses thereof | |
IL213698A0 (en) | Nucleoside phosphoramidates | |
IL210176A0 (en) | Substituted pyrimidone derivatives | |
AP2011005958A0 (en) | Uracyl spirooxetane nucleosides. | |
GB0706632D0 (en) | New purine derivatives | |
HK1142639A1 (en) | Stable recombinant adenosine deaminase | |
GB0803707D0 (en) | Antiviral agent | |
GB2469104B (en) | Dynamic rear wing | |
ZA201107883B (en) | Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives | |
IL219341A0 (en) | Heterocyclyl substituted arylindenopyrimidines and their use as highly selective adenosine a2a receptor antgonists | |
EP2426130A4 (de) | Purinderivat und antitumormittel damit | |
AU2012900791A0 (en) | 2',3' and 5' Riboside Modified Nucleosides | |
GB0703715D0 (en) | Novel modified nucleotides with antiviral activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120710 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/28 20060101ALI20130516BHEP Ipc: A61P 25/20 20060101ALI20130516BHEP Ipc: A61K 31/70 20060101ALI20130516BHEP Ipc: A61P 25/08 20060101ALI20130516BHEP Ipc: A61P 25/16 20060101ALI20130516BHEP Ipc: C07D 473/00 20060101ALI20130516BHEP Ipc: C07H 19/167 20060101AFI20130516BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130604 |
|
17Q | First examination report despatched |
Effective date: 20160229 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20180703 |